The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Post-TRIPS Options for Access to Patented Medicines in Developing Nations
Abstract
This article explores the tension between granting patent protection under the TRIPS Agreements and the availability of medicines at affordable prices to developing countries. A crucial consideration under the TRIPS compulsory licensing option is the ‘adequate remuneration’ paid. A theoretical and empirical analysis shows that the royalties set under past compulsory licenses have been much lower than those that would be established under the ‘foregone profits’ standard of US patent law. To respect comparative advantage in the supply of licensed drugs, the TRIPS language requiring that compulsory licensing be predominantly for domestic supply needs clarification. The multinational drug pricing strategy that best combines equity with coverage of R&D costs is a variant of Ramsey pricing, under which prices are much lower in nations with low ability to pay and/or high price elasticities of demand than in wealthy nations. Statistical evidence on the prices of 15 AIDS drugs in 18 low‐ and medium‐income nations reveals that tendencies toward Ramsey pricing were at best weak. To encourage Ramsey pricing, parallel exports should be barred from low‐income nations, and price controls should not benchmark the prices charged in low‐income nations. Outright donation can also enhance the supply of drugs to low‐income nations. A quantitative analysis shows that when the marginal cost of production is low relative to ‘inventoriable’ average cost, donations can actually enhance a drug producer's after‐tax profits under US tax laws. Minor tax law changes to enhance donation incentives are suggested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Appropriating the Returns from Industrial Research and Development
Levin, R. C., Klevorick, A. K., Nelson, R. R., Winter, S. G., Gilbert, R., & Griliches, Z. (1987) · Brookings Papers on Economic Activity · doi:10.2307/2534454 · Cited by 3,772
Cited by
Chaudhuri, S., Goldberg, P. K., & Jia, P. (2006) · American Economic Review · doi:10.1257/aer.96.5.1477 · Cited by 287
Pordié, L., & Gaudillière, J.-P. (2014) · East Asian Science, Technology and Society: An International Journal · doi:10.1215/18752160-2406053 · Cited by 84
Metadata
- Authors
- Scherer, F. M.
- Venue
- Journal of International Economic Law
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-01
- Volume
- 5
- Issue
- 4
- Pages
- 913-939
- ISSN
- 1369-3034 (ISSN-L)
- 1464-3758
- OpenAlex
- W1968054640
- Cited by
- 175
- References
- 1
- FWCI
- 19.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Post-TRIPS Options for Access to Patented Medicines in Developing Nations. https://app.cochat.ai/papers/10.1093/jiel/5.4.913
- The paper
- Scherer, F. M. (2002). Post-TRIPS Options for Access to Patented Medicines in Developing Nations. Journal of International Economic Law. https://doi.org/10.1093/jiel/5.4.913
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.